Lantern Pharma Inc. recently announced a partnership with the Poetic Alliance to launch a significant clinical trial at 14 leading cancer centers in the United States, Canada, and Israel.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Carro, backed by SoftBank, aims for "Nasdaq + Singapore Exchange" dual listing, with fundraising up to $500 million, potentially setting the first precedent for a dual listing in the US and Singapore.
According to informed sources, used car trading platform Carro is considering listing on the global board of the Singapore Exchange, which could make it the first company to adopt the new dual-listing mechanism between Nasdaq and the Singapore Exchange.
Storm Exploration discovers new VMS mineralized system at Gold Standard project in Ontario
Crypto prices
More
